Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

GeneDx Holdings (WGSWW) Accumulated Depreciation & Amortization (2020 - 2025)

GeneDx Holdings has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $9.6 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $9.6 million for Q4 2025, up 21.52% from a year ago — trailing twelve months through Dec 2025 was $9.6 million (up 21.52% YoY), and the annual figure for FY2025 was $9.6 million, up 21.52%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $9.6 million at GeneDx Holdings, up from $2.4 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for WGSWW hit a ceiling of $50.0 million in Q4 2022 and a floor of $1.7 million in Q1 2024.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $6.9 million (2024), compared with a mean of $11.0 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 129.28% in 2022 and later crashed 73.23% in 2023.
  • GeneDx Holdings' Accumulated Depreciation & Amortization stood at $21.8 million in 2021, then skyrocketed by 129.28% to $50.0 million in 2022, then crashed by 60.6% to $19.7 million in 2023, then plummeted by 59.9% to $7.9 million in 2024, then grew by 21.52% to $9.6 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $9.6 million (Q4 2025), $2.4 million (Q3 2025), and $4.5 million (Q2 2025) per Business Quant data.